SIXTY-EIGHTH WORLD HEALTH ASSEMBLY Agenda item 17.5
A68/B/CONF./1 Rev.1 25 May 2015
Global strategy and plan of action on public health, innovation and intellectual property Draft resolution proposed by the delegation of Bolivia (Plurinational State of), Brazil, Ecuador, India and South Africa1 The Sixty-eighth World Health Assembly, PP1 Having considered the report by the Secretariat on the global strategy and plan of action on public health, innovation and intellectual property,2 PP2 Recalling resolutions WHA61.21 and WHA62.16 on the global strategy and plan of action on public health, innovation and intellectual property that aims to promote new thinking on innovation and access to medicines, as well as, based on the recommendation of the report of the Commission on Intellectual Property Rights, Innovation and Public Health, provide a medium-term framework to secure an enhanced and sustainable basis for needs-driven, essential health research and development relevant to diseases that disproportionately affect developing countries, proposing clear objectives and priorities for research and development, and estimating funding needs in this area; PP3 Recognizing the central role the global strategy and plan of action on public health, innovation and intellectual property plays in directing and coordinating WHO’s policies and programme of work on public health, innovation and intellectual property; PP4 Welcoming resolution EBSS3.R1 entitled “Ebola: ending the current outbreak, strengthening global preparedness and ensuring WHO’s capacity to prepare for and respond to future large-scale outbreaks and emergencies with health consequences” which reaffirms the global strategy and plan of action on public health, innovation and intellectual property; PP5 Concerned about the pace of implementation of the GSPOA by stakeholders as defined in the Appendix of the GSPOA; PP6 Having considered the recommendations of the Executive Board to the Sixty-eighth World Health Assembly contained in decision EB136(17),
1 2
Reflecting the outcome of the informal drafting group held on 22/05. Document A68/35.
A68/B/CONF./1 Rev.1
(OP.1)
DECIDES:
(OP1.1) to extend the time frames of the plan of action on public health, innovation and intellectual property from 2015 until 2022; (OP1.2) to extend the deadline of the overall programme review of the global strategy and plan of action on public health, innovation and intellectual property on its achievements, remaining challenges and recommendations on the way forward to 2018, recognizing that it was not presented in 2015, as requested by resolution WHA62.16; (OP1.3) to undertake the comprehensive evaluation and overall programme review of the global strategy and plan of action on public health, innovation and intellectual property separately in a staggered manner as set out in document A68/35 and its Annex, in consultation with Member States1 subject to the process and provisions set out below; (OP.2) REQUESTS the Director General:
(OP2.1) to initiate, in line with the WHO Evaluation Policy and guided by the WHO Evaluation Practice Handbook, the comprehensive evaluation of the implementation of the global strategy and plan of action on public health, innovation and intellectual property in June 2015 as per the Terms of Reference specified in A68/35; to present the inception report and comments of the Evaluation Management Group for the consideration of the Executive Board at its 138th session in January 2016; and to submit the final comprehensive evaluation report for the consideration of the Seventieth World Health Assembly in 2017, through the Executive Board; (OP2.2) to convene an ad hoc Evaluation Management Group to assist the comprehensive evaluation composed of 6 independent external subject matter experts, and two evaluation experts from the United Nations Evaluation Group; (OP2.3) to select the 6 independent external subject matter experts in line with guidelines for selection of members for ad hoc evaluation management groups included in the WHO Evaluation Practice Handbook, including through consultation with the Regional Directors; (OP2.4) to establish a panel of 18 experts respecting gender balance, equal regional representation, and diversity of technical competence and expertise to conduct the overall programme review, with a broad and balanced mix of expertise, practical experience and backgrounds covering the eight elements of the global strategy and plan of action on public health, innovation and intellectual property, and including from developed and developing countries; (OP2.5) to invite Member States1 to nominate experts, including through the Regional Directors, for the roster beginning immediately following the 139th session of the Executive Board from which the Director-General will select the panel of 18 members for the overall programme review;
1
And, where applicable, regional economic integration organizations.
2
A68/B/CONF./1 Rev.1
(OP2.6) to present the Terms of Reference of the overall programme review for approval by the Executive Board at its 140th session in January 2017, and to present the composition of the overall programme review panel for consideration by the Bureau of the Executive Board in February 2017; (OP2.7) to present the final report of the overall programme review of the GSPOA, on its achievements, remaining challenges and recommendations on the way forward to the Seventy-first World Health Assembly in 2018 through the 142nd session of the Executive Board.
=
=
=
3